BAMF
MDCO

BI Asset Management Fondsmaeglerselskab’s Medicines Co MDCO Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,131
Closed -$107K – 458
2019
Q3 		$107K Buy
2,131
+232
+12% +$9.26K 0.01% 349
2019
Q2 		$69K Buy
+1,899
New +$62K ﹤0.01% 236

Other funds holding MDCO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's MDCO Position: Q4 2019 in Review

BI Asset Management Fondsmaeglerselskab sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 2,131 shares — an estimated $107K sold.

BI Asset Management Fondsmaeglerselskab first reported a position in MDCO in Q2 2019 and held it in 2 quarters. The position peaked at $107K in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • BI Asset Management Fondsmaeglerselskab reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 2,131 Medicines Co shares in Q4 2019, an estimated $107K.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Medicines Co in Q2 2019 and held it in 2 quarters.
  • BI Asset Management Fondsmaeglerselskab's Medicines Co position peaked at $107K in Q3 2019.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q4 2019, filed 19 Mar 2020.